Baseline C-reactive protein independently predicts treatment response and survival in metastatic melanoma patients receiving first-line immune checkpoint inhibitors.
Gambichler T, Ruhe C, Weyer-Fahlbusch SS, Susok L, Rached NA
European Journal of DermatologyIn the feed 6 Sep 2026, issue 2026 Aug 01, added to PubMed 6 Sep 2026
Topics: Skin cancer & tumors
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42702038 · DOI 10.1684/ejd.2026.5117